Since 1995, Equinox Group has provided analytics to support R&D decisions to biopharmaceutical companies, assessing the potential for drugs from discovery to launch, and anywhere in between. They have evaluated thousands of drug profiles across hundreds of indications in oncology, immunology, rare diseases, cardio-metabolic disorders, infectious diseases, neurology, respiratory, urology, ophthalmology, and endocrine disorders. They also have tailored methods to solve the unique analytical challenges that arise in oncology and rare diseases.
This dynamic firm has recently posted an opportunity for an entry level Research Associate. Visit their website for more information! And visit PCDC to ensure that your materials are in the best condition prior to applying!